By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Talecris Biotherapeutics GmbH 

Lyoner Strasse 15

Frankfurt    D-60528  Germany
Phone: 49-69-660-593100 Fax: 49-69-660-593110


Company News
NASDAQ Removes Talecris Biotherapeutics GmbH From Biotechnology Index Pending Federal Trade Commission Decision on Grifols Acquisition 2/15/2011 7:38:23 AM
Talecris Biotherapeutics GmbH Awards Winners of the 7th Annual European ALTA Research Fellowship at 2010 ERS Meeting 9/21/2010 8:23:09 AM
Talecris Biotherapeutics GmbH Forms Partnership to Co-Promote Life-Saving Rabies Products 6/15/2010 2:54:41 PM
Talecris Biotherapeutics GmbH Added to NASDAQ Biotechnology Index 5/17/2010 11:46:25 AM
Talecris Biotherapeutics GmbH Appoints Drayton Virkler as Senior Director, Investor Relations 1/8/2010 11:57:01 AM
Talecris Biotherapeutics GmbH Announces Private Offering of $550 Million Senior Notes Due 2016 10/13/2009 9:51:01 AM
Talecris Biotherapeutics Study Demonstrates Aerosolized Prolastin(R) Using Unique Nebulizer Results in High Levels of Drug Deposited in Peripheral Regions of Lungs 9/18/2007 11:47:33 AM
Crucell N.V. (CRXL) Announces European Protein Distribution Deal with Talecris Biotherapeutics 4/3/2007 10:31:39 AM